Breast cancer screening in high risk women
AUTOR(ES)
Gilbert, Fiona J.
FONTE
e-Med
RESUMO
Women who are at a significantly raised risk of developing breast cancer should be assessed by a medical geneticist to confirm their history, counselled as to appropriate management and offered breast screening. Currently mammography with magnetic resonance imaging is considered the optimal method of early detection of breast cancer in these women. While there is no evidence of mortality benefit there is evidence from surrogate markers that this intervention is worthwhile and cost effective. National recommendations have been produced by the National Institute of Clinical Excellence in the UK and also by the American Cancer Society.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2582500Documentos Relacionados
- Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).
- Risk of breast cancer in women who attend the NHS breast screening programme: cohort study
- Urinary estrogen metabolites in women at high risk for breast cancer
- Risk factors for breast cancer: relevance to screening.
- Ductal approaches to assessment and management of women at high risk for developing breast cancer